approved glp 1 drugs GLP-1s in the “Barbecue Belt Buckle” GLP-1 Agonists: A Comprehensive Overview

For persistent symptoms, intra-articular corticosteroid injections or duloxetine may be appropriate adjunctive therapies

SGLT2is compete with the SGLT2 protein for glucose binding in the renal tubules, causing an increase in glucose excretion, sodium, and water in urine and a decrease in blood glucose and reduced volume load [89,90,91]

44 In the latest clinical trials, namely the STEP-HFpEF and STEP-HFpEF-DM trials, semaglutide resulted in a significant reduction in C-reactive protein levels versus placebo in a pooled analysis of the two trials (43% versus 10%, respectively)

Key drug-disease associations covered include: 1